0.9269
Schlusskurs vom Vortag:
$0.9399
Offen:
$0.93
24-Stunden-Volumen:
156.87K
Relative Volume:
0.24
Marktkapitalisierung:
$36.52M
Einnahmen:
$69.26M
Nettoeinkommen (Verlust:
$-5.31M
KGV:
-6.1506
EPS:
-0.1507
Netto-Cashflow:
$-1.20M
1W Leistung:
-2.41%
1M Leistung:
+3.44%
6M Leistung:
-22.76%
1J Leistung:
-11.30%
Rockwell Medical Inc Stock (RMTI) Company Profile
Firmenname
Rockwell Medical Inc
Sektor
Telefon
(800) 449-3353
Adresse
30142 WIXOM ROAD, WIXOM, NJ
Compare RMTI vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
RMTI
Rockwell Medical Inc
|
0.9269 | 35.85M | 69.26M | -5.31M | -1.20M | -0.1507 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Rockwell Medical Inc Stock (RMTI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2019-06-24 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-05-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-08 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2016-03-01 | Herabstufung | Stifel | Buy → Hold |
| 2015-08-13 | Eingeleitet | Morgan Stanley | Underweight |
| 2015-01-27 | Bestätigt | Oppenheimer | Outperform |
| 2015-01-07 | Eingeleitet | Oppenheimer | Outperform |
| 2014-08-14 | Eingeleitet | FBR Capital | Underperform |
| 2013-12-19 | Eingeleitet | Chardan Capital Markets | Buy |
| 2013-11-06 | Bestätigt | Summer Street Research | Buy |
| 2013-09-05 | Bestätigt | Summer Street Research | Buy |
| 2013-08-02 | Bestätigt | Summer Street Research | Buy |
| 2012-04-11 | Eingeleitet | Summer Street Research | Buy |
| 2012-03-12 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-01-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2009-12-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2009-10-12 | Eingeleitet | Wedbush Morgan | Outperform |
Alle ansehen
Rockwell Medical Inc Aktie (RMTI) Neueste Nachrichten
EBITDA per share of Rockwell Medical, Inc. – BX:RWMA - TradingView — Track All Markets
Book value per share of Rockwell Medical, Inc. – BX:RWMA - TradingView — Track All Markets
Rockwell Medical tops earnings forecasts but shares slip on revenue decline - MSN
Rockwell Medical (RMTI) price target decreased by 20.00% to 3.06 - MSN
Moving Averages: What is Astera Labs Incs revenue forecast2026 Setups & Growth Oriented Trade Recommendations - baoquankhu1.vn
3 Biotech Stocks Surge with Momentum - National Today
Humana Goes Live with b.well to Deliver on Health Data Interoperability Commitments - Weekly Voice
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026 - Weekly Voice
ETF Watch: Is Rockwell Medical Inc part of any major index2026 Final Week & Short-Term High Return Strategies - baoquankhu1.vn
RKDA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Rockwell Medical (NASDAQ:RMTI) Price Target Lowered to $2.00 at HC Wainwright - Defense World
Recap Report: Is Rockwell Medical Inc benefiting from innovation trendsQuarterly Trade Review & AI Forecast Swing Trade Picks - baoquankhu1.vn
RMTI Analyst Rating Update: Price Target Lowered by HC Wainwrigh - GuruFocus
Layoff Watch: How sensitive is Rockwell Medical Inc to inflation2026 Sector Review & Daily Growth Stock Tips - baoquankhu1.vn
H.C. Wainwright cuts Rockwell Medical stock price target to $2 on sales miss By Investing.com - Investing.com South Africa
H.C. Wainwright cuts Rockwell Medical stock price target to $2 on sales miss - Investing.com
Rockwell Medical Earnings Call Balances Progress and Risk - The Globe and Mail
Rockwell Medical, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:RMTI) 2026-03-28 - Seeking Alpha
Analyst Upgrade: How much upside does TDSPRU have2026 Earnings & Daily Profit Focused Screening - baoquankhu1.vn
Rockwell Medical reports net loss of USD 0.6M in Q4 2025 - Medical Buyer
Maxim Group Maintains Rockwell Medical(RMTI.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Should Value Investors Buy Rockwell Medical (RMTI) Stock? - Yahoo Finance
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain - Yahoo Finance
Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2025 Earnings Call Transcript - insidermonkey.com
Rockwell Medical’s Cost Cuts Raise Execution Risk and Threaten Future Growth Prospects - TipRanks
Rockwell Medical, Inc. Reports Q4 and Full-Year 2025 Financial Results and Operational Highlights - Minichart
Rockwell Medical, Inc. Announces Corporate Presentation and Nasdaq Listing Update – March 26, 2026 - Minichart
Rockwell Medical Inc (RMTI) Q4 2025 Earnings Call Highlights: Na - GuruFocus
Rockwell Medical Inc (RMTI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Rockwell Medical 2025 Annual Report: Hemodialysis Product Innovations, Business Strategy, and Regulatory Compliance Overview - minichart.com.sg
Rockwell Medical targets $1M–$2M adjusted EBITDA and positive cash flow in 2026 as product mix diversifies - MSN
Commercial Metals Company (CMC) Reports Q2 Earnings - news.alphastreet.com
Rockwell Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Rockwell Medical (RMTI) Posts Fourth Quarter Loss, Falls Short of Revenue Projections - Bitget
Rockwell Medical (RMTI) Achieves Strong Q4 2025 Performance and Expands Customer Base - GuruFocus
Earnings Call Summary | Rockwell Medical(RMTI.US) Q4 2025 Earnings Conference - 富途牛牛
Rockwell Medical beats estimates but shares edge down on revenue drop - Investing.com Canada
Earnings call transcript: Rockwell Medical Q4 2025 beats EPS forecast By Investing.com - Investing.com South Africa
Earnings call transcript: Rockwell Medical Q4 2025 beats EPS forecast - Investing.com
Rockwell Medical Inc (NASDAQ:RMTI) Reports Q4 Revenue Miss but Highlights Margin Expansion and 2026 Profitability Outlook - ChartMill
Equillium Inc. 2025 Financial Review - AlphaStreet
Rockwell Med Updates Corporate Presentation for Investors - TipRanks
Rockwell Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Momentum Shift: Is Rockwell Medical Inc stock a top performer YTD2026 Closing Moves & Reliable Intraday Trade Alerts - baoquankhu1.vn
Rockwell Medical Reports 2025 Financial Results - AlphaStreet
Rockwell Medical (RMTI) furnishes updated corporate presentation in Form 8-K - Stock Titan
Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Rockwell Medical 2025 10-K: Revenue $69.3M, Operating loss $(4.7M) - TradingView
Rockwell Medical earnings beat by $0.07, revenue topped estimates - Investing.com Canada
Rockwell Medical (Nasdaq: RMTI) outlines 2025 risks, DaVita shift and cash - Stock Titan
Finanzdaten der Rockwell Medical Inc-Aktie (RMTI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):